Results 341 to 350 of about 4,684,794 (400)
Some of the next articles are maybe not open access.

Anticoagulation Therapy in Children

Seminars in Thrombosis and Hemostasis, 2003
Thromboembolic events (TEs) in children are rare but are becoming a recognized cause of morbidity and mortality, particularly in children with serious underlying primary conditions such as congenital heart disease, cancer, or prematurity. Neonates, infants, and adolescents are most at risk for developing TEs among children, and the presence of a ...
Anthony K.C. Chan, Shoshana Revel-Vilk
openaire   +6 more sources

Anticoagulation Therapy in Children [PDF]

open access: possibleSeminars in Thrombosis and Hemostasis, 2017
AbstractVenous thromboembolism (VTE) is very uncommon in children and adolescents compared with older adults, though its incidence has significantly increased over the past two decades. Given the rarity of the condition, the data on pediatric VTE lag behind the adult experience and consequently the management of VTE in children is, in large part ...
openaire   +2 more sources

Anticoagulant therapy with ancrod

Critical Reviews in Oncology/Hematology, 1993
5.7. 5.8 ......... . . Treatment of venous thromboembolism 5.1.1. Deep venous thrombosis 5.1.2. Pulmonaryembolus Prophylaxis of venous thromboembolism Other venous thrombotic disorders Treatment of arterial thromboembolism 5.4.
Jeffrey S. Ginsberg, R.L. Soutar
openaire   +3 more sources

Pharmacologic Therapies in Anticoagulation

Medical Clinics of North America, 2016
Anticoagulants are beneficial for prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation. The development of target-specific oral anticoagulants is changing the landscape of anticoagulation therapy and created growing interest on this subject.
Joyce E. Wipf, Joana Lima Ferreira
openaire   +3 more sources

Indications for Anticoagulant Therapy

New England Journal of Medicine, 1963
THE place of anticoagulant therapy in the various types and phases of occlusive vascular disease, venous and arterial, has been debated ever since its introduction into clinical practice more than fifteen years ago. The widely divergent opinions and seemingly conflicting results of therapeutic trials that have appeared are unmistakable symptoms of ...
openaire   +4 more sources

Anticoagulant therapy in practice

Orvosi Hetilap, 2012
Atrial fibrillation is a risk factor for ischemic stroke. To prevent stroke oral anticoagulants can be administered. Old and new types of anticoagulants are available. Nowadays, old type, acenocumarol based anticoagulants are used preferentially in Hungary.
Csilla Vér   +2 more
openaire   +3 more sources

Anticoagulant therapy in pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
Anticoagulation during pregnancy should derive benefit from recent advances in anticoagulant therapy. Unfractionated heparin is at present the drug of choice for most of the indications of thromboprophylaxis as well as for acute venous thrombosis during pregnancy but it is likely that, in the near future, low molecular weight heparins will supercede ...
Fabrice Lecuru   +4 more
openaire   +3 more sources

Indications for anticoagulant therapy

American Heart Journal, 1969
Abstract The value of anticoagulant therapy is solidly established in the presence of deepvein thrombosis and pulmonary embolism, in the presence of recurrent cerebral ischemic episodes when reparative vascular surgery is not possible, and in postoperative and bedridden patients, at least those with a high risk of pulmonary embolism.
Alan F. Lyon, Arthur C. DeGraff
openaire   +3 more sources

Anticoagulant Therapy—1974 [PDF]

open access: possibleJAMA: The Journal of the American Medical Association, 1974
THE national impact of thrombosis should not be underestimated. Arterial thromboembolism is a major, if not the primary, contributor to the number 1 (acute myocardial infarction), number 3 (stroke), and the number 4 (renal) causes of death in the United States.
openaire   +2 more sources

Atromid and Anticoagulant Therapy

Journal of Atherosclerosis Research, 1963
Summary Comparative survey of a limited number of cases has shown a tendency for the effects of Atromid and phenindione to be modified when both are given simultaneously. Phenindione may have some inhibiting influence upon the action of Atromid in lowering serum cholesterol, and Atromid increased the responsiveness of patients to phenindione. But it
M.J. Meynell   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy